These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 33655342)
21. Direct evidence of intra- and interhemispheric corticomotor network degeneration in amyotrophic lateral sclerosis: an automated MRI structural connectivity study. Rose S; Pannek K; Bell C; Baumann F; Hutchinson N; Coulthard A; McCombe P; Henderson R Neuroimage; 2012 Feb; 59(3):2661-9. PubMed ID: 21893207 [TBL] [Abstract][Full Text] [Related]
22. Role of diffusion tensor imaging or magnetic resonance spectroscopy in the diagnosis and disability assessment of amyotrophic lateral sclerosis. Liu C; Jiang R; Yi X; Zhu W; Bu B J Neurol Sci; 2015 Jan; 348(1-2):206-10. PubMed ID: 25524526 [TBL] [Abstract][Full Text] [Related]
23. Region-specific impairment of the cervical spinal cord (SC) in amyotrophic lateral sclerosis: A preliminary study using SC templates and quantitative MRI (diffusion tensor imaging/inhomogeneous magnetization transfer). Rasoanandrianina H; Grapperon AM; Taso M; Girard OM; Duhamel G; Guye M; Ranjeva JP; Attarian S; Verschueren A; Callot V NMR Biomed; 2017 Dec; 30(12):. PubMed ID: 28926131 [TBL] [Abstract][Full Text] [Related]
24. The combined use of conventional MRI and MR spectroscopic imaging increases the diagnostic accuracy in amyotrophic lateral sclerosis. Cervo A; Cocozza S; Saccà F; Giorgio SMDA; Morra VB; Tedeschi E; Marsili A; Vacca G; Palma V; Brunetti A; Quarantelli M Eur J Radiol; 2015 Jan; 84(1):151-157. PubMed ID: 25466774 [TBL] [Abstract][Full Text] [Related]
25. Cross-sectional and longitudinal assessment of the upper cervical spinal cord in motor neuron disease. van der Burgh HK; Westeneng HJ; Meier JM; van Es MA; Veldink JH; Hendrikse J; van den Heuvel MP; van den Berg LH Neuroimage Clin; 2019; 24():101984. PubMed ID: 31499409 [TBL] [Abstract][Full Text] [Related]
26. Interhemispheric connectivity in amyotrophic lateral sclerosis: A near-infrared spectroscopy and diffusion tensor imaging study. Kopitzki K; Oldag A; Sweeney-Reed CM; Machts J; Veit M; Kaufmann J; Hinrichs H; Heinze HJ; Kollewe K; Petri S; Mohammadi B; Dengler R; Kupsch AR; Vielhaber S Neuroimage Clin; 2016; 12():666-672. PubMed ID: 27761397 [TBL] [Abstract][Full Text] [Related]
28. Value of fluid-attenuated inversion recovery MRI data analyzed by the lesion segmentation toolbox in amyotrophic lateral sclerosis. Wirth AM; Johannesen S; Khomenko A; Baldaranov D; Bruun TH; Wendl C; Schuierer G; Greenlee MW; Bogdahn U J Magn Reson Imaging; 2019 Aug; 50(2):552-559. PubMed ID: 30569457 [TBL] [Abstract][Full Text] [Related]
29. A longitudinal diffusion tensor MRI study of the cervical cord and brain in amyotrophic lateral sclerosis patients. Agosta F; Rocca MA; Valsasina P; Sala S; Caputo D; Perini M; Salvi F; Prelle A; Filippi M J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):53-5. PubMed ID: 18931009 [TBL] [Abstract][Full Text] [Related]
30. Distinct patterns of progressive gray and white matter degeneration in amyotrophic lateral sclerosis. Ishaque A; Ta D; Khan M; Zinman L; Korngut L; Genge A; Dionne A; Briemberg H; Luk C; Yang YH; Beaulieu C; Emery D; Eurich DT; Frayne R; Graham S; Wilman A; Dupré N; Kalra S Hum Brain Mapp; 2022 Apr; 43(5):1519-1534. PubMed ID: 34908212 [TBL] [Abstract][Full Text] [Related]
31. Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs. Jaiswal MK Med Res Rev; 2019 Mar; 39(2):733-748. PubMed ID: 30101496 [TBL] [Abstract][Full Text] [Related]
32. Hyperintensity of the corticospinal tract on FLAIR: A simple and sensitive objective upper motor neuron degeneration marker in clinically verified amyotrophic lateral sclerosis. Jin J; Hu F; Zhang Q; Jia R; Dang J J Neurol Sci; 2016 Aug; 367():177-83. PubMed ID: 27423585 [TBL] [Abstract][Full Text] [Related]
34. Two Decades-Long Journey from Riluzole to Edaravone: Revisiting the Clinical Pharmacokinetics of the Only Two Amyotrophic Lateral Sclerosis Therapeutics. Dash RP; Babu RJ; Srinivas NR Clin Pharmacokinet; 2018 Nov; 57(11):1385-1398. PubMed ID: 29682695 [TBL] [Abstract][Full Text] [Related]
35. Brain white matter abnormalities and correlation with severity in amyotrophic lateral sclerosis: An atlas-based diffusion tensor imaging study. Du XQ; Zou TX; Huang NX; Zou ZY; Xue YJ; Chen HJ J Neurol Sci; 2019 Oct; 405():116438. PubMed ID: 31484082 [TBL] [Abstract][Full Text] [Related]
36. Edaravone: a new hope for deadly amyotrophic lateral sclerosis. Bhandari R; Kuhad A; Kuhad A Drugs Today (Barc); 2018 Jun; 54(6):349-360. PubMed ID: 29998226 [TBL] [Abstract][Full Text] [Related]
37. Structural explanation of poor prognosis of amyotrophic lateral sclerosis in the non-demented state. Kim HJ; Oh SI; de Leon M; Wang X; Oh KW; Park JS; Deshpande A; Buj M; Kim SH Eur J Neurol; 2017 Jan; 24(1):122-129. PubMed ID: 27753163 [TBL] [Abstract][Full Text] [Related]
39. Effect of edaravone therapy in Korean amyotrophic lateral sclerosis (ALS) patients. Park JM; Kim SY; Park D; Park JS Neurol Sci; 2020 Jan; 41(1):119-123. PubMed ID: 31471712 [TBL] [Abstract][Full Text] [Related]